Sharecare’s stock is up 19c, or 20%, to $1.13 in early Wednesday trading following a regulatory filing made earlier that revealed that on October 3, John Chadwick, a member of the board of directors of Sharecare, submitted a preliminary non-binding proposal to the board on behalf of Claritas Capital, related to the proposed acquisition, directly or indirectly, by Claritas and/or their affiliated investment funds of all of the shares of common stock not beneficially owned by the reporting persons for cash consideration of between $1.35 and $1.80 per share. “Each of Mr. Chadwick and the other the Reporting Persons reserve the right to modify or withdraw the Proposal at any time for any reason, including but not limited to an inability to secure financing for the Proposal on acceptable terms or at all and the satisfactory completion of due diligence, and no binding obligation on the part of any of Mr. Chadwick, Claritas Capital, the other Reporting Persons or any of their affiliates will arise with respect to submission of the Proposal or the filing of this Statement,” the filing stated. The board has not yet responded to the proposal, the filing added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SHCR:
- Sharecare to report third quarter fiscal 2023 financial results on Thursday, November 9
- Winners of Sharecare Awards revealed live at HLTH on Monday, Oct. 9
- Sharecare issues Community Well-Being Index 2022 state rankings report
- Sharecare to participate in Morgan Stanley 21st Annual Global Healthcare Conference
- Sharecare deep discount valuation unwarranted, says Canaccord